AERIE PHARMACEUTICALS INC

Profile

Company Names

AERIE PHARMACEUTICALS INC

Addresses

135 US HIGHWAY 206, SUITE 15, BEDMINSTER, NJ 07921

1140 ROUTE 22 EAST, SUITE 303, BRIDGEWATER, NJ 08807

7020 KIT CREEK ROAD, SUITE 270, RESEARCH TRIANGLE PARK, NC 27709

Phone Numbers

908-470-4320
919-313-9650

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$186,614,965.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2014-09-08 
$125,000,000.00 
$125,000,000.00 
$0.00 
Debt 
3
2012-12-07 
$15,000,000.00 
$18,000,000.00 
$3,000,000.00 
Debt 
2
2011-02-23 
$41,364,965.00 
$41,364,965.00 
$0.00 
Equity 
1
2010-08-27 
$5,250,000.00 
$5,250,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VICENTE 
 
ANIDO 
EXECUTIVE OFFICER, DIRECTOR
AERIE PHARMACEUTICALS INC
GERALD 
 
CAGLE 
DIRECTOR
ALDEXA THERAPEUTICS, INC.   |  AERIE PHARMACEUTICALS INC   |  GRAYBUG LLC   |  GRAYBUG, INC.   |  GRAYBUG VISION, INC.   |  NACUITY PHARMACEUTICALS, INC.
JANET 
 
CONWAY 
DIRECTOR
AERIE PHARMACEUTICALS INC
MITCHELL 
 
DELONG 
EXECUTIVE OFFICER
AERIE PHARMACEUTICALS INC
GEOFFREY 
 
DUYK 
DIRECTOR
AERIE PHARMACEUTICALS INC   |  AMYRIS, INC.   |  NUVAIRA, INC.
DAVID 
 
EPSTEIN 
EXECUTIVE OFFICER, DIRECTOR
AERIE PHARMACEUTICALS INC   |  2100 FREEDOM, INC.   |  METASTAT, INC.   |  BACK9BEVERAGES LLC   |  RUBIUS THERAPEUTICS, INC.   |  PALMIA CORP
MURRAY 
 
GOLDBERG 
DIRECTOR
NEW UNIVERSITY HOLDINGS CORP.   |  AERIE PHARMACEUTICALS INC
DAVID 
 
GRYSKA 
DIRECTOR
HYPERION THERAPEUTICS INC   |  ARGOS THERAPEUTICS INC   |  AERIE PHARMACEUTICALS INC   |  FORTE BIOSCIENCES, INC.   |  MIND MEDICINE (MINDMED) INC.
DENNIS 
 
HENNER 
DIRECTOR
SARCODE CORP   |  PROACTA INC   |  SARCODE BIOSCIENCE INC.   |  KALOBIOS PHARMACEUTICALS INC   |  AERIE PHARMACEUTICALS INC   |  CLARUS LIFESCIENCES III, L.P.   |  CLARUS DEFINED EXIT I, L.P.   |  CLARUS DE II, L.P.   |  IMAGO BIOSCIENCES, INC.   |  FORTY SEVEN, INC.   |  CLEAVE BIOSCIENCES, INC.
CASEY 
 
KOPCZYNSKI 
EXECUTIVE OFFICER
AERIE PHARMACEUTICALS INC
BRIAN 
 
LEVY 
EXECUTIVE OFFICER
OCULAR THERAPEUTIX, INC   |  AERIE PHARMACEUTICALS INC   |  INSITE VISION INC   |  VISION PATH, INC.   |  SILK TECHNOLOGIES, LTD.   |  OCUNEXUS THERAPEUTICS, INC.   |  INFLAMMX THERAPEUTICS, INC.   |  ZILKS PLUS RESOURCES LLC   |  PUP ABOVE, INC.   |  CONCIERGE PEDIATRICS HOLDINGS, LLC
DAVID 
 
MACK 
DIRECTOR
PROACTA INC   |  AERIE PHARMACEUTICALS INC   |  PATHWORK DIAGNOSTICS INC   |  AFFINOR GROWERS INC.   |  PMV PHARMACEUTICALS, INC.   |  NORTH CYPRESS LAND VENTURES POB, LTD.
JAMES 
 
MAZZO 
DIRECTOR
AERIE PHARMACEUTICALS INC   |  IANTREK, INC.   |  NEUROTRIGGER LTD.   |  KYS VISION, INC.
ANAND 
 
MEHRA 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  VICEPT THERAPEUTICS, INC.   |  AERIE PHARMACEUTICALS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  SPARK THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  FIRST AID BEVERAGES, INC.   |  SOFINNOVA VENTURE PARTNERS X, L.P.   |  MERUS N.V.   |  AMPLYX PHARMACEUTICALS, INC.
THOMAS 
 
MITRO 
EXECUTIVE OFFICER
AERIE PHARMACEUTICALS INC
THOMAS 
J 
MITRO 
EXECUTIVE OFFICER
AERIE PHARMACEUTICALS INC
RICHARD 
 
RUBINO 
EXECUTIVE OFFICER
AERIE PHARMACEUTICALS INC   |  BEST AGENT TODAY, INC.   |  INFLAMMX THERAPEUTICS, INC.   |  FIGUR8, INC.
THOMAS 
 
VAN HAARLEM 
EXECUTIVE OFFICER, DIRECTOR
AERIE PHARMACEUTICALS INC
THOMAS 
J 
VAN HAARLEM 
EXECUTIVE OFFICER, DIRECTOR
AERIE PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-09-23
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2014-09-08 
2013-08-29
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2012-12-07 
2012-12-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-07 
2011-03-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-23 
2010-09-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-08-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#